Articles Tagged With: Pfizer-BioNTech
-
FDA Streamlining COVID-19 Shot to a Single Formula
Conceding the various vaccine doses and multiple boosters have caused considerable confusion, and some degree of pandemic apathy, the FDA’s Vaccines and Related Biological Products Advisory Committee unanimously voted to simplify and “harmonize” the process by switching to a single vaccine formula to be administered annually for most people.
-
Winter of Our Discontent: Omicron Variant Pushes Healthcare to Brink
With omicron causing much higher breakthrough infection rates than previous COVID-19 variants, there is concern infected healthcare workers must isolate amid an ongoing nursing shortage. The previous recommendation for 10 days has been changed to seven, and shorter than that under certain conditions. -
CDC Quickly Reverses ACIP’s Vote Against Booster Shots for HCWs
In a highly unusual move, CDC Director Rochelle Walensky, MD, MPH, overruled her own vaccine advisory committee when they became mired in a far-ranging debate about COVID-19 booster shots that led to an end-of-the day vote not to recommend them for healthcare workers. -
COVID-19 Vaccine mRNA Injection (Comirnaty)
Comirnaty is the first COVID-19 vaccine to receive full FDA approval.
-
Fauci: Vaccine Booster Should Spark Strong Immune Response
Healthcare workers are expected to be a priority for COVID-19 vaccine booster shots this fall, providing more protection against the highly transmissible delta variant and likely reducing breakthrough infections. -
FDA Approval of Pfizer Shot Opens Floodgates for Mandates
Many hospitals and healthcare facilities are expected to mandate COVID-19 vaccination for employees now that the FDA has removed the emergency use authorization label and fully licensed the Pfizer-BioNTech vaccine. It is expected the full licensure will now encourage vaccine mandates and requirements beyond healthcare settings.